Alcoholism and panic disorder: is the comorbidity more than coincidence?

Acta Psychiatrica Scandinavica

Volumn 81, Issue 2, 1990, Pages 97-107

  George, D T ^a   Nutt, D J ^b   Dwyer, B A ^c   Linnoila, M ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b Reckitt & Colman   (United Kingdom)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

alcoholism; comorbidity; panic disorder

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE; NORADRENALIN;

ALCOHOLISM; CENTRAL NERVOUS SYSTEM; HUMAN; PANIC; PSYCHOLOGICAL ASPECT; REVIEW; THEORETICAL STUDY; WITHDRAWAL SYNDROME;

ALCOHOLISM; ANIMAL; ANXIETY DISORDERS; FEAR; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; HUMAN; KINDLING (NEUROLOGY); NOREPINEPHRINE; PANIC; RISK FACTORS;

EID: 0025333915     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1990.tb06460.x     Document Type: Article

References (130)

1. Die agoraphobie: Eine neuropathische Erscheinung
2. Life time prevalence of specific psychiatric disorders in three sites
3. Alcohol dependence and phobias; clinical description and relevance
4. Alcoholism, anxiety disorders and agoraphobia
5. Alcohol dependence and phobic anxiety states. I. A prevalence study
6. Prevalence of anxiety disorder among alcoholics
7. Clinical phobias and avoidant personality disorder among alcoholics admitted to an alcoholism rehabilitation setting
8. Alcohol use and abuse among diagnosed agoraphobics
9. Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness
10. Personality of panic disorder alcohol abusers
11. Affective disorder and alcoholism in families of agoraphobics
12. Panic disorder and major depression. Increased risk of depression, alcoholism, panic, and phobic disorders in families of depressed probands with panic disorder
13. Relationship between panic disorder and agoraphobia
14. A comparison of two diagnostic methods: clinical ICD diagnoses vs DSM‐III and Research Diagnostic Criteria using the Diagnostic Interview Schedule (version 2)
15. Alcohol and human behavior.
16. Alcohol and mood: an updated review
17. Alcohol dependence and phobic anxiety states. II. A retrospective study
18. Panic attacks and alcohol withdrawal: Can subjects differentiate the symptoms
19. Urinary norepinephrine and epinephrine excretion in delirium tremens
20. Arterial noradrenaline levels after ethanol withdrawal
21. Cerebrospinal fluid 3‐methoxy‐4‐hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal
22. Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers
23. Efficacy of clonidine in treatment of alcohol withdrawal state
24. Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin‐aldosterone system, and clinical symptoms
25. Alpha‐2‐adrenoceptor function in alcohol withdrawal: a pilot study of the effects of IV clonidine
26. Randomized clinical trial of atenolol in patients with alcohol withdrawal
27. Pressor effect of moderate alcohol consumption in man: a proposed mechanism
28. Changes in plasma noradrenaline, 3, 4‐dihydroxyphenylethylene glycol and blood pressure following acute ethanol administration
29. The effect of ethyl alcohol on the secretion from the adrenal medulla in man
30. Ethanol and urinary catecholamines in man
31. Acute effects of alcohol on left ventricular function in healthy subjects at rest and during upright exercise
32. Cardiovascular effects of alcohol
33. Effects of ethanol on plasma catecholamines and norepinephrine clearance
34. The peripheral and central role of the catecholamines in the mechanisms of anxiety
35. The psychophysiology of anxiety with a review of the literature concerning adrenaline
36. Behavioral effects of stimulation of the nucleus locus coeruleus in the stump‐tailed monkey
37. The midbrain and pain.
38. Neurochemical basis for anxiety and anxiety disorders: evidence from drugs which decrease human fear or anxiety.
39. Hyperdynamic B‐adrenergic circulatory state
40. Biochemical factors in anxiety neurosis
41. Lactate provocation of panic attacks. II. Biochemical and physiological findings
42. Adrenergic function in patients with panic anxiety
43. Ambulatory heart rate changes during panic attacks
44. Lactate and hyperventilation substantially attenuate vagal tone in normal volunteers
45. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder
46. Panic‐induced elevation of plasma MHPG levels in phobic‐anxious patients. Effects of clonidine and imipramine
47. Situational panic attacks. Behavioral, physiologic and biochemical characterization
48. Sympathetic nervous system activity in panic disorder
49. Altered central alpha‐2‐adrenoceptor sensitivity in panic disorder
50. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder
51. Blunted growth hormone response to clonidine in panic patients
52. Monoamine function in anxiety and depression. Information from neuroendocrine challenge tests
53. Effects of clonidine on anxiety disorders
54. Biochemical and histochemical studies on the effects of imipramine‐like drugs and (+) ‐amphetamine on central and peripheral catecholamine neurons
55. Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons
56. Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: alpha receptor mediation
57. Decrease in brain NE turnover after chronic DMI treatment: no effect with iprindole
58. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression
59. Abrupt discontinuation of tricyclic antidepressant drugs: evidence for noradrenergic hyperactivity
60. Ethanol specifically potentiates GABA‐mediated neurotransmission in feline cerebral cortex
61. The effects of GABA and benzodiazepine receptor antagonist on the anti‐conflict actions of diazepam or ethanol
62. The interactions of ethanol with benzodiazepine‐GABA receptor‐ionophore complex
63. Drug therapy; alcohol intoxication and alcohol withdrawal
64. Diazepam loading: simplified treatment of alcohol withdrawal
65. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study
66. Diazepam and propranolol in panic disorder and agoraphobia
67. Is Ro 15‐4513 a specific alcohol antagonist
68. Alcohol withdrawal reactions in mice: effects of drugs that modify neurotransmission
69. A selective imidazobenzodiazepine antagonist of ethanol in the rat
70. The benzodiazepine receptor inverse agonists FG 7142 and Ro 15‐4513 both reverse some of the behavioral effects of ethanol in a holeboard test
71. RO 15‐4513 induces seizures in DBA/2 mice undergoing alcohol withdrawal
72. Plasma GABA levels in chronic alcoholics
73. GABA receptors are increased in brains of alcoholics
74. The anxiogenic action of benzodiazepine antagonists
75. A benzodiazepine receptor‐mediated model of anxiety
76. Pharmacological and behavioral studies of benzodiazepine antagonists and contragonists.
77. Severe anxiety induced by FG 7142, a B carboline ligand for benzodiazepine receptors
78. Can drug effect on anxiety and convulsions be separated
79. Benzodiazepines attenuate single unit activity in the locus coeruleus
80. Single unit activity of locus coeruleus neurons in the freely moving cat. II. Conditioning and pharmacologic studies
81. Low doses of ethanol disrupt sensory responses of brain noradrenergic neurons
82. A single dose of FG 7142 causes long‐term increases in mouse cortisol B‐adrenoceptors
83. An anxiogenic benzodiazepine receptor ligand induces learned helplessness
84. Development of epileptic seizures through brain stimulation at low intensity
85. A permanent change in brain function resulting from daily electrical stimulation
86. Progressive effects of cocaine on behavior and central amine metabolism in rhesus monkeys: relationship to kindling and psychosis
87. Progressive behavioral changes during chronic lidocaine administration: relationship to kindling
88. Cocaine, kindling and psychosis
89. A study of the action of valproic acid on the kindling effect
90. Effects of diazepam and phenobarbital on electrically‐induced amygdaloid seizures and seizure development
91. Kindling: secondary epileptogenesis, sleep and catecholamines
92. Effects of atropine, reserpine, 6‐hydroxydopamine, and handling on seizure development in the rat
93. The effects of alcohol on the central nervous system in humans.
94. Electroencephalographic changes associated with chronic alcohol intoxication and the alcohol abstinence syndrome
95. Electroencephalographic and behavioral correlates in rats during repeated ethanol withdrawal syndromes
96. Alcohol withdrawal in mice: electroencephalographic and behavioral correlates
97. Potentiation of ethanol withdrawal by prior dependence
98. Ethanol dependence in the rat: role of non‐specific and limbic regions in the withdrawal reaction
99. Systemic ethanol: selective enhancement of responses to acetylcholine and somatostatin in hippocampus
100. Intensification of the alcohol withdrawal syndrome by repeated brain stimulation
101. Circadian rhythms of cortisol during alcohol withdrawal
102. Glucocorticoids and hippocampal damage
103. et al. Pituitary adrenocortical unresponsiveness in lactate‐induced panic
104. Kindling as a model for alcohol withdrawal syndromes
105. Phases of alcohol addiction
106. Severity of alcohol dependence and its relationship to additional psychiatric symptoms in male alcoholic patients
107. Information processes of the brain
108. Anxiety reconceptualized
109. A theory of the incubation of anxiety/fear responses
110. Principles of nervous breakdown ‐ schizokinesis and autokinesis
111. A cognitive approach to panic
112. Ideational components of anxiety: their origin and content
113. Hyperventilation as a cause of panic attacks
114. The application of positron emission tomography to the study of panic disorder
115. Pavlovian conditioning and ethanol tolerance
116. The contribution of pavlovian conditioning to drug tolerance and dependence
117. Conditioned compensatory response to alcohol placebo in humans
118. Dissociation of alcohol tolerance and dependence
119. The effects of 6‐hydroxydopamine on tolerance to nd dependence on alcohol
120. Panic response to lactate administration in alcoholic and non‐alcoholic patients with panic disorder
121. Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse
122. The efficacy of AA attendance for aftercare of inpatient alcoholics: some follow‐up data
123. Alcoholics Anonymous: affiliation processes and effectiveness as treatment
124. Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo
125. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms
126. Assessing the potential for buspirone dependence or abuse and effects of its withdrawal
127. Alcohol and drug interactions with anti‐anxiety mediations
128. Long‐term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone
129. Acute and chronic effects of the benzodiazepines receptor ligand FG 7142: proconvulsant properties and kindling